Table 3.
Management practice | Categories | Frequency (N) | Percentage (%) |
Medication history | Enalapril | 73 | 12.2 |
Oral hypoglycaemic | 45 | 7.5 | |
Nifedipine | 54 | 9.0 | |
Hydrochlorothiazide | 38 | 6.4 | |
Nifedipine+hydrochlorothiazide | 32 | 5.4 | |
Atorvastatin | 27 | 4.5 | |
Phenytoin | 24 | 4.0 | |
Insulin | 15 | 2.5 | |
Others* | 25 | 4.2 | |
None | 264 | 44.2 | |
Medications used to treat stroke during hospitalisation | ASA+atorvastatin | 352 | 59.0 |
Supportive therapy/physiotherapy | 103 | 17.3 | |
ASA | 54 | 9.0 | |
Atorvastatin | 52 | 8.7 | |
ASA+atorvastatin+physiotherapy | 36 | 6.0 | |
Concomitantly administered drugs for hospitalised patients who had a stroke | Cimetidine | 154 | 25.8 |
Ceftriaxone+metronidazole+cimetidine | 110 | 18.4 | |
Heparin | 71 | 11.9 | |
Ceftriaxone+metronidazole | 52 | 8.7 | |
Mannitol | 52 | 8.7 | |
Bisacodyl | 43 | 7.2 | |
Metoprolol | 34 | 5.7 | |
Warfarin | 30 | 5.0 | |
Mannitol+ranitidine | 32 | 5.4 | |
Ceftriaxone+cimetidine | 19 | 3.2 | |
Medications give at discharge for treatment of stroke | ASA | 321 | 53.8 |
ASA+atorvastatin | 97 | 16.2 | |
Atorvastatin | 78 | 13.1 | |
Concurrently prescribed drug prescribed during discharge | Nifedipine | 147 | 24.6 |
Metoprolol | 91 | 15.2 | |
Ranitidine | 89 | 14.9 | |
Enalapril | 82 | 13.7 | |
Omeprazole | 41 | 6.9 | |
Phenytoin | 28 | 4.7 | |
Digoxin | 18 | 3.0 |
*HAART, salbutamol, antibiotics and anticancer.
ASA, acetylsalicylic acid (aspirin); HAART, highly active antiretroviral therapy.